MG1131
/ GC Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 01, 2022
Structural and functional characterization of a monoclonal antibody blocking TIGIT.
(PubMed, MAbs)
- "MG1131 also increased T cell infiltration to the tumor site and inhibited tumor growth in mice. Collectively, these data indicate that MG1131 modulates the effector functions of T cells and NK cells positively and Treg cells negatively."
Journal • Hematological Malignancies • Immune Modulation • Inflammation • Multiple Myeloma • Oncology • IFNG • TIGIT
1 to 1
Of
1
Go to page
1